v3.25.2
NOTE 9 - RESEARCH & DEVELOPMENT
3 Months Ended
Jan. 31, 2025
Research and Development [Abstract]  
NOTE 9 - RESEARCH & DEVELOPMENT

NOTE 9 - RESEARCH & DEVELOPMENT  

 

During the period ended January 31, 2025, the Company incurred research and development expenses of $160,465 for products the Company intends to offer for sale in the future.

 

During the period ended January 31, 2024, the Company incurred research and development expenses of $179,625 for products the Company intends to offer for sale in the future.